EIP Pharma, Inc. — Form D
EIP Pharma, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2021-12-23. The offering totals $10.0M, of which $6.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-12-23
- Form: D
- Accession: 0001736525-21-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $10.0M
- Amount sold: $6.0M
- Remaining: $4.0M
- Minimum investment: $1.0M
- Investors: 3
- Date of first sale: 2021-12-10
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-426627
Issuer
- Name: EIP Pharma, Inc.
- CIK: 0001736525
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 20 PARK PLAZA, SUITE 424, BOSTON, MA, 02116
- Phone: 617-744-4400
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| SYLVIE GREGOIRE | Executive Officer | Boston, MA |
| JEFF POULTON | Director | Boston, MA |
| WILLIAM TURNER | Executive Officer | Boston, MA |
| SYLVIE GREGOIRE | Director | Boston, MA |
| FRANK ZAVRL | Director | BOSTON, MA |
| KELLY BLACKBURN | Executive Officer | BOSTON, MA |
| JOHN ALAM | Director | BOSTON, MA |
| JOHN ALAM | Executive Officer | BOSTON, MA |
| MARWAN SABBAGH | Director | Boston, MA |
| Tatjana May | Director | Boston, MA |
| Noel Donnelly | Executive Officer | Boston, MA |
Other filings by this issuer (5)
More